5Heinemann V,Jehn U,Acute myeloid leukemia in the eiderly:Biological features and search for adequate treatment.Aan Hematol.1991;63:179.
6Foon RA,Zighelboim J,Yale C.et al.Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia.Blood.1981;58:467.
7Tilly H,Castaigne S.Bordessoule D.et al.Low-does cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients.Cancer,1985;55:1633.
8Powell BL,Capizzi RL.Muss HB,et al.Lowdoes AraC therapy for acute myelogenous leukemia in the elderly patients.Leukemia,1989;3:23.
9V. Heinemann,U. Jehn. Acute myeloid leukemia in the elderly: biological features and search for adequate treatment[J] 1991,Annals of Hematology(4):179～188
5Mori M.Laboratory features of acute myelogenous leukemia in elderly patients[J].Rinsho Byori,2001,49(5):433.
6Benzin J,Lang K,Earle C C,et al.The outcomes and costs of acute myeloid leukemia among the elderly[J].Arch Inter Med,2002,22(162):1597-1603.
7Haferlach T,Schoch C,Loffler H,et al.Morphologic dysplasia in de novo actue myeloid leukemia(AML) is related to unfavorable cytogenetics but has no independent prognostic relevance,under the conditions of intensive induction therapy:results of a multiparamenter analysis from the German AML Cooperative Group studies[J].J Clin Oncol,2003,21(2):256-265.
